Stock UniverseDerived research view · source repositories remain read-only

Phathom Pharmaceuticals, Inc. (PHAT)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Watch
Selection Score
31.72
Global Rank
1700
Market Cap
989.71M
Latest Close
10.13
RS Composite
-25.78% · G#2881

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-20.05%
3M
-5.06%
6M
-30.95%
1Y
115.53%
3Y
-13.86%
5Y
-71.34%
10Y
-58.82%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 1.14M · 30-day average: 1.41M · Max drawdown over stored range: -95.81%

Research Snapshot

Relative Strength vs SPX

RS Composite-25.78%
20D RS-17.81%
60D RS-18.08%
120D RS-37.47%
Global RS Rank2881 · 14.13% percentile
Watch+Speculative RS Rank1768 · 15.69% percentile
Group ScopeWatch+Speculative
Primary RS Rank339 · 25.98% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank206 / 701
Primary Percentile70.76
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-04-30204.89M174.02M-96.60M-157.30M-2.09-330.08M405.00K-330.49M75M84.93%-47.15%-76.77%-1.61%-1.61%180.90M163.68M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$-2.09-4.9x$2.723.7x$-4.38-2.3x$-4.38-2.3x

Shares Diluted: 75M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue0000.68255.252175.11
Revenue Growth (YoY)2900%2900%2900%2900%8001.466%216.93%
Gross Profit0000.51547.279152.511
Operating Income-125.665-135.08-172.44-167.312-277.467-159.986
Free Cash Flow-70.728-148.785-147.571-139.214-266.905-167.004
Free Cash Flow Per Share-2.129-4.021-3.772-2.714-4.225-2.29
EPS (Diluted) GAAP-3.884295-3.888418-5.054499-3.930504-5.29196-3.034157
EPS Growth
EPS Non-GAAP
Gross Margin2900%2900%2900%75.513%85.57%87.094%
Operating Margin2900%2900%2900%-24532.551%-502.185%-91.363%
Profit Margin2900%2900%2900%-29558.944%-605.093%-126.347%
Free Cash Flow Margin2900%2900%2900%-20412.61%-483.068%-95.371%
Shares Outstanding (Diluted)33.228237.00339.118251.289163.176272.9188
Shares Change (YoY)192.323%11.36%5.716%31.113%23.177%15.421%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-04-3058.30M79.42%-15.48M-26.55%-30.37M-52.09%-0.3782.05M180.90M163.68Mprocessed
2025 Q42026-02-2657.58M86.72%-5.93M-10.29%-21.15M-36.73%-0.2973.83M129.97M209.09Mprocessed
2025 Q32025-10-3049.50M87.50%-15.27M-30.85%-29.97M-60.55%-0.4173.40M135.16M207.09Mprocessed
2025 Q22025-08-0739.50M87.25%-59.92M-1.52%-75.81M-1.92%-1.0572.47M149.57M205.14Mprocessed
2025 Q12025-05-0128.52M86.94%-78.86M-2.77%-94.32M-3.31%-1.3171.97M212.31M203.25Mprocessed
2024 Q42025-03-0629.66M87.14%-59.42M-2.00%-74.45M-2.51%-1.0571.07M297.26M201.41Mprocessed
2024 Q32024-11-0716.35M85.59%-70.80M-4.33%-85.58M-5.23%-1.3264.63M334.68M175.73Mprocessed
2024 Q22024-08-087.32M81.21%-77.30M-10.55%-91.45M-12.49%-1.5658.56M276.24M174.42Mprocessed
2024 Q12024-05-091.91M77.72%-69.95M-36.59%-82.85M-43.33%-1.4258.37M322.23M149.02Mprocessed
2023 Q42024-03-07n/an/a-69.88Mn/a-79.57Mn/a-1.3957.36M381.39M137.84Mprocessed
2023 Q32023-11-09n/an/a-35.66Mn/a-43.24Mn/a-0.7656.78M213.68M99.26Mprocessed
2023 Q22023-08-10n/an/a-31.70Mn/a-40.97Mn/a-0.8448.50M248.85M97.81Mprocessed
2023 Q12023-05-10n/an/a-30.08Mn/a-37.81Mn/a-0.8942.35M129.57M96.64Mprocessed
2022 Q42023-02-28n/an/a-46.64Mn/a-55.05Mn/a-1.3341.33M155.38M95.26Mprocessed
2022 Q32022-11-08n/an/a-42.53Mn/a-51.09Mn/a-1.3238.82M196.84M93.88Mprocessed
2022 Q22022-08-02n/an/a-45.36Mn/a-50.92Mn/a-1.3338.27M207.39M92.43Mprocessed
2022 Q12022-05-10n/an/a-37.91Mn/a-40.66Mn/an/an/a138.09M91.04Mprocessed
2021 Q42022-03-01n/an/a-33.04Mn/a-35.83Mn/an/an/a183.26M89.67Mprocessed
2021 Q32021-11-08n/an/a-33.14Mn/a-36.66Mn/an/an/a224.62M88.31Mprocessed
2021 Q22021-08-10n/an/a-35.32Mn/a-36.55Mn/an/an/a209.67M37.34Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.